CSI uses 10-color flow cytometry – a sophisticated method for providing diagnosis, prognosis, and monitoring of malignancies with a relatively small sample size. With our skilled flow technologists and hematopathologists, we are quickly able to identify emerging abnormalities and perform rare event analysis of patient-specific aberrant immunophenotypes.
As the front line for cancer testing and a key factor in determining downstream testing, CSI Laboratories’ platform is one of the most advanced flow cytometry testing services on the market today. CSI flow provides:
- An advanced 10-color platform yielding more information per tube
- Full characterization of low cellularity samples
- A proprietary panel design for reduced interference of co-expression
- Viability dye in all tubes to exclude non-viable events for improved analysis
- Kappa/Lambda combined in a single tube for B-cell abnormalities
- Client re-gating with FCS Express Reader
- Expert hematopathology consult services for difficult flow cytometry cases
- Antibody panel formulations personalized for each case to maximize accurate diagnoses
- Paroxysmal Nocturnal Hemoglobinuria (PNH) testing using high sensitivity FLAER-based analysis to diagnose and monitor PNH clones for treatment using eculizumab therapy
